for the Period Ended 30 September 2024
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
As at
Notes | 2024 | 2023 | |
---|---|---|---|
|
£ |
£ |
|
Current assets | |||
Debtors: | 3 |
|
|
Cash at bank and in hand: |
|
|
|
Total current assets: |
|
|
|
Net current assets (liabilities): |
|
|
|
Total assets less current liabilities: |
|
|
|
Accruals and deferred income: |
(
|
(
|
|
Total net assets (liabilities): |
|
|
|
Members' funds | |||
Profit and loss account: |
|
|
|
Total members' funds: |
|
|
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 September 2024
Basis of measurement and preparation
for the Period Ended 30 September 2024
2024 | 2023 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 30 September 2024
2024 | 2023 | |
---|---|---|
£ | £ | |
Trade debtors |
|
|
Total |
|
|
Debtors due after more than one year: |
|
|
The Association of Zimbabwean Pharmacists Abroad CIC (AZPA CIC) is a Community Interest Company formed to support the professional development of Zimbabwean pharmacists living in the United Kingdom, while also contributing to the improvement of healthcare and pharmaceutical education in Zimbabwe. During the financial year [insert year range], the company’s activities have benefited the community in the following ways: UK-based Zimbabwean pharmacists have been supported through professional networking events, mentoring opportunities, and information sharing platforms, enabling them to maintain their professional standards and stay engaged with developments in both the UK and Zimbabwean pharmacy sectors. The company has facilitated donations of academic materials and equipment to the University of Zimbabwe’s School of Pharmacy through its ongoing “Library Project”, helping to strengthen pharmaceutical education in Zimbabwe and ensure future generations of pharmacists have access to up-to-date learning resources. AZPA CIC has provided a platform for Zimbabwean healthcare professionals in the UK diaspora to reconnect and collaborate on health improvement initiatives, including CPD events and strategic partnerships with health training services. The organisation has begun exploratory work on community benefit schemes, including a bulk-buying initiative for basic goods and a proposed medical cover solution for dependants of pharmacists in Zimbabwe, with the aim of reducing financial pressures on diaspora families and improving welfare. The company has strengthened relationships with small-scale Zimbabwean producers of medical or educational resources, helping some of them gain access to diaspora-led distribution or donation networks in the UK. Through its volunteering and project management structure, AZPA CIC has offered project coordination and administrative experience to at least 3 individuals within the UK-based Zimbabwean professional community, supporting skills development and leadership capacity.
During the financial year 2024, AZPA CIC has actively engaged with its stakeholders primarily UK based Zimbabwean pharmacists, alumni of the University of Zimbabwe School of Pharmacy, and affiliated healthcare professionalsthrough regular online meetings, surveys, and project planning sessions. These consultations have guided the organisation’s priorities, including the expansion of the Library Project, the exploration of diaspora-based welfare schemes, and partnerships with training providers. Stakeholder feedback has been instrumental in shaping the company’s activities, ensuring they remain relevant, inclusive, and responsive to the evolving needs of both the diaspora community and pharmacy education stakeholders in Zimbabwe. The Board also remains open to informal feedback through member forums and email channels, reinforcing AZPA CIC’s commitment to transparency and collaboration
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
27 June 2025
And signed on behalf of the board by:
Name: Thomas Thomik
Status: Director